This inventor holds 1 USPTO granted patent. Top assignee: Europaisches Laboratorium Molekularbiologie. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: David Cregut: Innovator in Cytokine Antagonists
Introduction
David Cregut is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of molecular biology, particularly in the design of pharmaceutical agents. His work focuses on the development of antagonists for specific cytokine receptors, which are crucial in various biological processes.
Latest Patents
David Cregut holds a patent titled "Coiled-coil dimer derived antagonists of 4-helix bundle cytokines, design and uses thereof." This patent discloses the design of antagonists that target 4-helix bundle cytokine specific receptors. It also includes mimetic peptides that can act as antagonists, highlighting their potential use as pharmaceutical agents. He has 1 patent to his name.
Career Highlights
Cregut is affiliated with the European Molecular Biology Laboratory, where he continues to advance his research. His work has implications for therapeutic developments in treating various diseases linked to cytokine signaling.
Collaborations
Throughout his career, David has collaborated with esteemed colleagues such as Hartmut Oschkinat and Walter Sebald. These collaborations have enriched his research and contributed to the advancement of knowledge in the field.
Conclusion
David Cregut is a prominent figure in the realm of molecular biology, with a focus on cytokine antagonists. His innovative work and collaborations continue to pave the way for advancements in pharmaceutical applications.